Results 271 to 280 of about 64,328 (314)
Some of the next articles are maybe not open access.

Salbutamol: in profile

Practice Nursing, 1997
Sue Silverman's new series profiles some of the most routinely prescribed drugs. The first looks at the beta-2 agonist, Salbutamol.
openaire   +2 more sources

Salbutamol for transient tachypnea of the newborn

Cochrane Database of Systematic Reviews, 2015
Transient tachypnea of the newborn is characterized by tachypnea and signs of respiratory distress. Transient tachypnea typically appears within the first two hours of life in term and late preterm newborns. Although transient tachypnea of the newborn is usually a self limited condition, it is associated with wheezing syndromes in late childhood.
Alberto Gaiero   +4 more
openaire   +3 more sources

SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?

Drug Testing and Analysis, 2015
The study was designed to investigate the effect of a common genetic variation of the main salbutamol metabolizing enzyme SULT1A3 (single nucleotide polymorphism 105A>G, rs1975350) on the stereoselective pharmacokinetics of salbutamol.
G. Jacobson   +3 more
semanticscholar   +1 more source

Theoretical and experimental research on the self-assembled system of molecularly imprinted polymers formed by salbutamol and methacrylic acid.

Journal of Separation Science, 2015
The quantum chemical method was applied for screening functional monomers in the rational design of salbutamol-imprinted polymers. Salbutamol was the template molecule, and methacrylic acid was the single functional monomer. The LC-WPBE/6-31G(d,p) method
Liu Jun-bo   +3 more
semanticscholar   +1 more source

Dependency upon Salbutamol Inhalers

British Journal of Psychiatry, 1979
SummaryA case of dependency on salbutamol inhalers has been described. This has been discussed in relation to abuse of other drugs by alveolar absorption and other effects of salbutamol. It is not known whether the dependency is due to the salbutamol itself or to the fluorinated hydrocarbons used as propellants.
J G Edwards, S T Holgate
openaire   +3 more sources

Hypokalemia and salbutamol therapy in asthma

Pediatric Pulmonology, 1999
Hypokalemia is a common side effect in adult asthmatic patients on beta 2 adrenergic therapy. There is limited information in regard to hypokalemia and its relation to the clinical responses following administration of beta 2 agonist therapy in children with asthma.
Kuender D. Yang   +3 more
openaire   +3 more sources

Synthesis of a salbutamol dimer

Tetrahedron Letters, 2002
Abstract First synthesis of the diastereomeric mixture of Salbutamol dimer ( 2 ) is described. The synthesis provides access to multi-gram quantities of 2 for reference supplies and further analytical and toxicology investigations. It also confirmed the proposed structure by comparison to authentic sample.
James A. Baron   +3 more
openaire   +2 more sources

Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes.

Drug Testing and Analysis, 2014
Our objective was to investigate urine concentrations of 8 mg oral salbutamol in samples collected after intense exercise in endurance athletes. Nine male endurance athletes with a VO2max of 70.2 ± 5.9 mL/min/kg (mean ± SD) took part in the study.
M. Hostrup   +6 more
semanticscholar   +1 more source

Postponement of Preterm Birth with Salbutamol

International Journal of Gynecology & Obstetrics, 1979
ABSTRACTSalbutamol was administered intravenously and orally to 58 patients who were admitted to the hospital because of premature labor. Pregnancy was postponed until at least 36 weeks' gestation in 34 of these patients. The success of this therapy was measured by a parameter of the prolongation index which was inversely related to the Bishop's score.
TambyRaja, R.L.   +2 more
openaire   +3 more sources

Salbutamol as an adjuvant for nasal vaccination

Vaccine, 1999
Salbutamol, a beta-adrenergic agonist, which transiently increases cAMP levels, was tested for its potential adjuvant activity in nasal vaccination. SAG1, the major surface protein of Toxoplasma gondii was used as vaccinating protein to protect CBA mice from a challenge with the parasite. Mice, vaccinated with SAG1 in the presence of salbutamol, showed
Paola Ricciardi-Castagnoli   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy